Catalyst Wire Dossier Catalyst Wire Dossier

Methylphenidate Hydrochloride Controlled Release Capsules

methylphenidate hydrochloride controlled release
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Methylphenidate Hydrochloride Controlled Release Capsules, covering 2023-10-26 to 2023-10-26. Get the full timeline:

Most recent: Clinical Trial Update: A 14 Week, Randomized, Placebo-Controlled Cross-Over Study of Methylphenidate Hydrochloride Controlled Release Capsules in Adult ADHD With and Without Anxiety Disorder Comorbidity [Phase 4]

See pricing